Rarecells
PrivateLast Round
Series A
Dec 9, 2021
Total Funding Raised
$13M
Company Overview
Rarecells operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in December 2021.
Rarecells is a biotechnology company that develops a liquid biopsy system designed for the early-stage detection of cancer using circulating tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarecells Comparables
Compare Rarecells with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SmartCatch | 88% | |
| ScreenCell | 86% | |
| Cell Microsystems | 83% |
For institutional investors. Book with your work email.
Rarecells Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
New data from BioMolCTC Trial presented at lung cancer conference.
- Sep 9, 2025
Presented new data at the IASLC World Conference on Lung Cancer.
For institutional investors. Book with your work email.
Rarecells Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rarecells's valuation, stock price, and market status.
Is Rarecells a public or private company?
Rarecells is a private company.
What is the current stock price of Rarecells?
Rarecells is a private company, so its shares have no public market price. Caplight tracks Rarecells's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rarecells worth (valuation)?
Valuation information for Rarecells is not publicly available.
Can I buy Rarecells stock?
Rarecells shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rarecells's last funding round?
Rarecells's most recent funding round was Series A on December 9, 2021.
Who are the main investors in Rarecells?
Investor information for Rarecells is not publicly disclosed.
Will Rarecells IPO soon?
No public IPO plans have been announced for Rarecells.
How can I track Rarecells secondary market activity?
Caplight tracks bids, offers, and trades in Rarecells's shares on secondary markets.